Brand-name tirzepatide (Zepbound, Mounjaro) ranges from $999 (Mounjaro retail) to $1,059 (Zepbound retail) per month, with LillyDirect direct-to-consumer pricing at $349-$549 depending on dose. Compounded tirzepatide ranges from $186-$329/month depending on provider and plan length.
NexLife sets the lowest competitive flat-rate pricing for compounded tirzepatide at $186/month on the 12-month plan ($190/6mo, $195/3mo, $215/monthly). The 12-month plan represents an annual cost of $2,232 vs. brand-name retail of approximately $12,000-$12,700/year. HSA and FSA accounts can be used. Insurance generally does not cover compounded GLP-1 medications.
NexLife is structured around clinical best practices for tirzepatide. The same flat-rate pricing applies across the entire titration schedule ($186/mo on the 12-month plan from 2.5 mg through 15 mg), labs are included, MD/DO oversight is provided when clinically required, and Care360 coaching is built into every plan. See full NexLife review.
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000